BRIEF published on 03/31/2026 at 14:30, 6 months 18 days ago Le vaccin contre la maladie de Lyme de Valneva est prometteur malgré le non-respect du critère d'évaluation principal. Objectif De Cours Valneva SE Approbation De La FDA Essai De Phase 3 Vaccin Contre La Maladie De Lyme
BRIEF published on 03/31/2026 at 14:21, 6 months 18 days ago Worthington Steel's Successful Takeover of Klöckner & Co: Key Details Takeover Offer Mergers & Acquisitions Klöckner & Co Shareholder Acceptance Worthington Steel
BRIEF published on 03/31/2026 at 14:21, 6 months 18 days ago Rachat réussi de Klöckner & Co par Worthington Steel : points clés Offre Publique D'achat Klöckner & Co Fusions Et Acquisitions Acceptation Des Actionnaires Acier Worthington
BRIEF published on 03/31/2026 at 14:10, 6 months 18 days ago Whatfix Study: Enterprises Risk $10.9M Loss from Poor Digital Adoption AI Integration Governance Financial Loss Enterprise Technology Digital Adoption
BRIEF published on 03/31/2026 at 14:10, 6 months 18 days ago Étude Whatfix : Les entreprises risquent une perte de 10,9 millions de dollars en raison d’une faible adoption du numérique Gouvernance Intégration De L'IA Technologie D'entreprise Perte Financière Adoption Numérique
BRIEF published on 03/31/2026 at 14:10, 6 months 18 days ago Zvoove Group Bolsters Cleaning Industry Solutions with KleanApp Acquisition Digital Operations Cleaning Industry Europe Expansion Zvoove Group KleanApp Acquisition
BRIEF published on 03/31/2026 at 14:10, 6 months 18 days ago Le groupe Zvoove renforce ses solutions pour l'industrie du nettoyage avec l'acquisition de KleanApp. Expansion Européenne Industrie Du Nettoyage Opérations Numériques Groupe Zvoove Acquisition De KleanApp
BRIEF published on 03/31/2026 at 14:05, 6 months 18 days ago Proxygen Names Chiara Conti as Chief Scientific Officer Biotechnology Clinical Development Molecular Glue Degraders Proxygen GmbH Chiara Conti
BRIEF published on 03/31/2026 at 14:05, 6 months 18 days ago Proxygen nomme Chiara Conti au poste de directrice scientifique Biotechnologie Développement Clinique Dégradeurs De Colle Moléculaire Proxygen GmbH Chiara Conti
BRIEF published on 03/31/2026 at 14:05, 6 months 18 days ago Lonza Nominates Stephen Fry as Independent Board Member Pharmaceutical Industry Governance Organizational Transformation Lonza Board Stephen Fry
Published on 10/17/2026 at 03:20, 1 day 15 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 1 day 15 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 1 day 19 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 1 day 19 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 1 day 19 hours ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/18/2026 at 14:05, 4 hours 47 minutes ago UEG launches new Patient Representatives Advisory Board to strengthen patient voice in digestive health
Published on 10/17/2026 at 18:00, 1 day ago Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 1 day 5 hours ago Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 1 day 6 hours ago AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 1 day 22 hours ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:54, 1 day 22 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 2 days ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 2 days ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
